IndraLab

Statements

Lipopolysaccharide inhibits UCHL1. 2 / 2

| 2

reach

"Four days of IA LPS exposure causes a decreased PGP9.5- and S100beta positive surface area in the myenteric plexus along with submucosal and mucosal intestinal inflammation that coincided with systemic inflammation."

| PMC

➶

reach

"Four days of IA LPS exposure causes a decreased PGP9.5- and S100beta positive surface area in the myenteric plexus along with submucosal and mucosal intestinal inflammation that coincided with systemic inflammation."

32883198

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Lipopolysaccharide inhibits UCHL1. 2 / 2

INDRA sources:

Databases

Reading